We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Register Free
Advertise with Us
Latest Issue
Latest Issue
RANDOX LABORATORIES

Download Mobile App




In Other News

Image: Biocare is now part of Agilent’s Life Sciences and Diagnostics Markets Group, expanding the company’s pathology portfolio across clinical and research settings

Agilent Strengthens Pathology Capabilities Through Biocare Acquisition

Biocare is now part of Agilent’s Life Sciences and Diagnostics Markets Group, expanding its clinical and research pathology portfolio. Read more
29 Jun 2026 | Industry
Image: The planned Bio-Techne acquisition would strengthen Merck KGaA, Darmstadt, Germany, in multi-omics, spatial biology, cell and gene therapy, precision diagnostics, and research tools.

Merck KGaA to Acquire Bio-Techne, Expanding Life Science Portfolio

Merck KGaA agrees to acquire Bio-Techne, strengthening its leadership position in fast-growing life sciences markets. Read more
29 Jun 2026 | Industry
Image: Researchers reveal that in Sjögren disease, an autoimmune disease, not only immune cells but also the fibroblasts that make up the tissue are actively involved in the progression of the disease. CD153+ CD4+ T cells interact with CD30+ fibroblasts in primary Sjögren disease, amplifying inflammation and tissue damage. This pathological cellular interaction represents a potential therapeutic target for autoimmune Sjögren disease. (Photo courtesy of Professor Koji Yasutomo, Tokushima University, Japan)

New Cellular Biomarkers Correlate with Disease Severity in Sjögren Disease

New findings reveal an immune-fibroblast pathway in primary Sjögren disease that may serve as a novel biomarker for diagnosis or monitoring. Read more
26 Jun 2026 | Immunology
Image: a new initiative aims to bring greater precision to this class of therapeutics (Photo courtesy of One Biosciences)

Project Aims to Develop First Single-Cell Assay for ADC Therapies

One Biosciences receives Paris Saclay Cancer Cluster BOOST funding to advance a single-cell assay approach for antibody-drug conjugate therapies. Read more
26 Jun 2026 | Industry
Image: The study identified an unexpected immune signature in active TB, showing that disease is marked not by a weak immune response but by a distinct inflammatory profile (Photo courtesy of Shutterstock)

Airway Immune Signature May Predict Tuberculosis Progression Risk

New findings map airway immune signatures that predict TB progression versus control. Read more
26 Jun 2026 | Immunology
Image Credit: Shutterstock

Ultrasensitive ctDNA Assay Detects MRD in Breast, Colorectal, Renal Cancers

Myriad Genetics has expanded availability of Precise MRD to treatment and surveillance for breast, colorectal, and renal cancers.  Read more
26 Jun 2026 | Molecular Diagnostics
Image: Researchers identified three biologically distinct severe pneumonia subtypes that may enable more precise, patient-specific treatment (Photo courtesy of Shutterstock)

Lung Immune Profiling Reveals Distinct Severe Pneumonia Subtypes

Researchers identify three severe pneumonia pneumotypes missed by blood tests, predicting recovery and guiding targeted therapy. Read more
26 Jun 2026 | Immunology
Image: The proposed immunoassay uses ALZpath’s pTau217 antibody to detect Alzheimer’s disease biology in blood, supporting the growing role of blood-based biomarkers in clinical care (Photo courtesy of Shutterstock)

Agreement Supports pTau217-Based Alzheimer’s Blood Test Development

ALZpath is licensing its proprietary pTau217 antibody to Abbott for development of an Alzheimer’s disease IVD test. Read more
26 Jun 2026 | Industry
Image: A four‑protein signature can identify pediatric IBD and distinguish its subtypes (Image credit: iStock)

Blood Protein Signature Diagnoses Pediatric IBD and Distinguishes Subtypes

A new four-protein blood test identifies pediatric IBD and distinguishes Crohn's from ulcerative colitis noninvasively. Read more
25 Jun 2026 | Clinical Chem.
Image: New findings indicate that chimeric RNAs, once viewed as cancer byproducts, can also be part of normal physiology with regulatory functions (Image credit: Adobe Stock)

Female-Specific RNA Biomarker May Help Explain Sex Differences in Immune Disease

Researchers identify a female-specific chimeric RNA that tracks COVID-19 severity, informing blood-based risk stratification. Read more
25 Jun 2026 | Molecular Diagnostics
Image: Blue represents nuclei and pink represents dead or dying cells. Bottom right: Cells are overexpressing the BIRC3 variant which is seen in green. (Photo courtesy of The Hospital for Sick Children)

Genetic Marker Supports Anti-TNF Therapy Selection in Crohn’s Disease

New findings identify Crohn’s-linked genetic changes that may help stratify patients and guide anti-TNF therapy. Read more
25 Jun 2026 | Molecular Diagnostics
Image: An uncertainty‑aware framework strengthens AI reliability for cancer histology subtyping (Image credit: Shutterstock)

Uncertainty-Aware AI Tool Improves Digital Pathology for Cancer Subtyping

An uncertainty-aware AI approach boosts pathology, flagging out-of-scope inputs and meeting accuracy targets in cancer subtyping. Read more
25 Jun 2026 | Pathology
Image: Volition’s Nu.Q NETs test detects markers associated with neutrophil extracellular traps, which are released during NETosis and linked to sepsis and other acute and chronic disorders (Image credit: iStock)

Collaboration Aims to Broaden Access to NETosis-Linked Disease Testing

VolitionRx announced a collaboration with Sysmex Corporation to optimize Volition’s Nu.Q NETs H3.1 assay on the Sysmex platform.  Read more
25 Jun 2026 | Industry
Image: Findings showed that the Stockholm3 blood test detected more clinically significant prostate cancers than PSA testing without increasing unnecessary testing (Image credit: 123RF)

Blood Test Detects More High-Risk Prostate Cancers Than PSA

A new blood test detects more aggressive prostate cancers than PSA without increasing unnecessary testing. Read more
24 Jun 2026 | Clinical Chem.

Channels

Clinical Chemistry

view channel
Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth
Blood-Based Alzheimer’s Testing Platform Offers Rapid Results
Simple Oral Swab Monitors Persistent Inflammation in Primary Ciliary Dyskinesia
Image: NSE-FAST is a rapid, enzyme-based luminescence assay that quantifies neuron specific enolase activity in blood plasma, using TETmedical’s patented Tethered Enzyme Technology to measure this biomarker of acute ischemic stroke (Photo courtesy of TET Medical)

Rapid Blood Test Aids Diagnosis of Acute Ischemic Stroke

Rapid and accurate differentiation of stroke types remains a persistent challenge in emergency medicine, particularly because early imaging can miss ischemic events that require time-sensitive intervention.... Read more

Molecular Diagnostics

view channel
RNA Blood Test May Enable Earlier Alzheimer’s Disease Diagnosis
AI Reasoning Model Generates Diagnostic Leads for Unresolved Rare Disease Cases
Point-of-Care Molecular Test Detects Group A Strep in Minutes
Image: The findings represent an important precision oncology milestone, independently confirming that endocrine activity in HR+/HER2− breast tumors can predict sensitivity to specific chemotherapy approaches (Image Credit: Adobe Stock)

Genomic Test Guides Taxane-Based Chemotherapy Selection in Breast Cancer

Selecting adjuvant chemotherapy for hormone receptor–positive, HER2-negative (HR+/HER2−) breast cancer remains challenging because current genomic assays mainly estimate recurrence risk rather than predict... Read more

Hematology

view channel
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Higher Ferritin Threshold May Improve Iron Deficiency Detection in Children
Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia
Image: Sysmex America’s next generation XR-Series, a hematology solution designed to help busy laboratories deliver fast, reliable results while maintaining efficient workflows (Photo courtesy of Sysmex America)

Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows

Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more

Immunology

view channel
Antibody Profiles Provide Clues to Long COVID Severity and Symptoms
Aptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Image: Lead author Muhammad Zia Ullah Khan examines a Petri dish containing a cell suspension. Fluorescence and bright-field images of cells in microchannels, displayed on the monitor, visualize immune cell communication (Photo courtesy of Technical University Munich)

Lab-on-a-Chip Approach Advances Immune–Cancer Cell Interaction Analysis

Conventional cytotoxicity assays often average responses across thousands of cells, obscuring how individual immune cells engage and kill tumor cells. For immunotherapy evaluation, the precise sequence... Read more

Microbiology

view channel
Stronger Laboratory Services Support Timely Melioidosis Diagnosis Amid Global Sp...
Extracellular Vesicle Biomarker May Enable Noninvasive Monitoring of H. pylori
Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE
Image: Multidrug-resistant Klebsiella pneumoniae is a growing community health concern, causing recurrent UTIs in older adults and complicating first-line antibiotic treatment (Image Credit: Adobe Stock)

Study Reveals Widespread Community Spread of Drug-Resistant Klebsiella

Multidrug-resistant Klebsiella pneumoniae is an escalating community health concern, driving recurrent urinary tract infections in older adults and complicating first-line antibiotic therapy.... Read more

Pathology

view channel
Stain-Free Imaging Platform Matches Standard Cancer Pathology
New Companion Diagnostic Expands Precision Medicine in Prostate Cancer
Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cance...
Image: Biomarker testing is critical for lung cancer therapy selection, yet ordering delays mean biopsy-to-result turnaround still averages about 27 days, according to a new study (image credit: Shutterstock)

Study Highlights Biomarker Testing Delays in Lung Cancer Care

Timely biomarker results are critical to match lung cancer patients with targeted therapies or immunotherapies, yet many clinical pathways still delay testing after biopsy. Ordering responsibility, reimbursement... Read more

Technology

view channel
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance
Image: Foundation Medicine will launch advanced digital solutions integrated with Roche’s navify Clinical Hub to deliver personalized insights to U.S. providers at the point of care (Photo courtesy of Roche)

AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines

Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more

Industry

view channel
QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools
Partnership Expands Ultrasensitive Blood-Based Diagnostics for Hematologic Malig...
Open-Source Consortium Aims to Standardize Digital Pathology Workflows
Image: At the core of the collaboration is Pirche’s TxPredictor platform, which uses proprietary algorithms to analyze histocompatibility and predict immunological risk (Photo courtesy of Pirche AG)

Partnership Aims to Improve Transplant Monitoring Across Care Continuum

Allograft rejection and chronic graft dysfunction remain major challenges in solid organ transplantation, requiring careful immunologic matching and long-term surveillance. Fragmented pre- and post-transplant... Read more

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Terms of Service
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
BioResearch
Industry
Events
Focus
Webinars

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica ExpoHospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2026
ADLM WHX Labs Dubai 2025
Medica ADLM MEDLAB 2024
Medica

 

ADLM Medlab 2023
Medica AACC EUROMEDLAB Medlab 2022
MEDICA AACC
Copyright © 2000-2026 Globetech Media. All rights reserved.
MOBILE | FULL SITE